{"nct_id":"NCT02689284","title":"Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer","status":"COMPLETED","status_verified_date":"2025-02","start_date":"2016-01","start_date_type":"ACTUAL","primary_completion_date":"2021-01","primary_completion_date_type":"ACTUAL","completion_date":"2021-01","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["MGNX"]}